Newest first. 5.2k questions across 107 tags.
Conditions: BCH · Zhuhai · Finland. I am trying to build something sustainable rather than something thorough that I will abandon. I have already decided the broad…
What I have: cagrilintide · 37 °C · seven days. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum…
I would like to know how much of this is established and how much is a reasonable story. This should be a straightforward calculation and I keep getting two different…
Conditions: WWB · retatrutide. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s interpretation…
I have continuous temperature data for the period in question, which is unusual and I would like to use it. I have a result I cannot explain, and I would rather…
What I have: injection-site erythema · 1,000 kcal. I have a result I cannot explain, and I would rather diagnose it than guess. I have checked the obvious…
Stated plainly: JEEP · Bachem Holding (Suzhou). I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a…
Concretely: headache · cagrilintide · REDEFINE-1. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a…
Conditions: Shanghai · Australia. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result, which…
Concretely: aspartimide formation · tirzepatide · minus 80 °C. I want to know whether this is a real physical effect or an artefact of how it is measured. What…
Concretely: 1 mg/mL · tirzepatide. I would like the axes of comparison first and the recommendation second. I have tried the first option and it works; the question…
What I am working with: liraglutide · ten weeks. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit…
The specifics, since they change the answer: deamidation · a wide-pore C18 column. I would like the mechanism, because I want to be able to reason about the cases…
I have the full paper rather than the abstract, and the supplementary appendix. I would rather understand the derivation than memorise the outcome. Two people I asked…
For reference: fatigue · 1,000 kcal. An unexpected observation, and I would like a differential rather than reassurance. The conditions were within what I understood…
The method section is present, which is unusual enough that I want to make use of it. I would like help reading this properly rather than being told what conclusion…
Setup, so nobody has to ask: ERP · ChinaPeptides (QYAOBIO). Both of these get recommended confidently by different people, which suggests neither is obviously right.…
Setup, so nobody has to ask: 1 mg/mL · a GLP-1 receptor agonist. Both of these get recommended confidently by different people, which suggests neither is obviously…
The lot number on the vial matches the certificate, which at least rules out the easy problem. I keep seeing this stated as a fact with no explanation attached, and…
Concretely: orforglipron · fourteen days. This is a procedural question rather than a theoretical one, and I would like the procedure rather than the theory. What I…
What I am working with: 96.4% · Medutest · 95.2% · Janoshik. Both of these get recommended confidently by different people, which suggests neither is obviously right.…
What I have: mazdutide · a C8 column · semaglutide. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
Details up front: STEP 4 · 2 mg. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree, which…
I have three data points across nine months, which I hope is enough to see a trend. I suspect the usual explanation for this is wrong, or at least incomplete. I am…